PTPI

0.002112.50%
BT

Bruce T. Bernstein

Independent Chairman of the Board

Mr. Bruce T. Bernstein is Director of Q/C Technologies, Inc. (formerly known as TNF Pharmaceuticals, Inc.) from September 2025. Mr. Bernstein serves as an Independent Director at Wrap Technologies, Inc. since April 21, 2023 and Petros Pharmaceuticals, Inc. since December 2020. He joined Petros Pharmaceuticals, Inc. in 2020. He has been an Independent Director at RRE Ventures Acquisition Corp. since April 29, 2026. Mr. Bernstein has been the Independent Chairman of the Board at XWELL, Inc. (formerly known as XpresSpa Group, Inc.) since February 05, 2018 and serves as its Independent Director February 8, 2016. He has been an Independent Director of TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) (formerly Neurotrope Bioscience, Inc.) since November 14, 2016 and is its Independent Vice-Chairman of the Board since October 2025. Mr. Bernstein served as Managing Partner and President of Rockmore Capital, LLC since 2006 until February 2017. Mr. Bernstein has experience in the securities industry, primarily as senior portfolio manager for two alternative finance funds as well as in trading and structuring of arbitrage strategies. Mr. Bernstein serves as senior portfolio manager for two alternative finance funds as well as in trading and structuring of arbitrage strategies. He served as Co-President of Omicron Capital, LP, an investment firm based in New York, which he joined in 2001. Prior to joining Omicron Capital, Mr. Bernstein was with Fortis Investments Inc., where he served as Senior Vice President in the bank's Global Securities Arbitrage business unit, specializing in equity structured products and equity arbitrage and then President in charge of the bank's proprietary investment business in the United States. Prior to Fortis, Mr. Bernstein served as Director in the Equity Derivatives Group at Nomura Securities International specializing in cross-border tax arbitrage, domestic equity arbitrage and structured equity swaps. Mr. Bernstein started his career at Kidder Peabody, where he rose to the level of Assistant Treasurer. Mr. Bernstein serves as a Member of the Board of Directors of XpresSpa Holdings. He had been an Independent Director of Neurotrope, Inc. since November 14, 2016 until 2020 and has been Independent Director at XpresSpa Group, Inc (formerly known as FORM Holdings Corp) since February 08, 2016. He serves as Director of Summit Digital Health, a laser-based blood glucose monitor distributor. Mr. Bernstein's banking, accounting and finance expertise enable him to contribute valuable insights into accounting and financial matters for the Petros Pharmaceuticals, Inc. Mr. Bernstein holds a B.B.A. from City University of New York (Baruch).

Positions